Cite
HARVARD Citation
Sadeghi, S. et al. (2023). EphrinB2 Inhibition and Pembrolizumab in Metastatic Urothelial Carcinoma. Journal of clinical oncology. 41 (3), pp. 640-650. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Sadeghi, S. et al. (2023). EphrinB2 Inhibition and Pembrolizumab in Metastatic Urothelial Carcinoma. Journal of clinical oncology. 41 (3), pp. 640-650. [Online].